318 related articles for article (PubMed ID: 17438062)
1. First case of emergence of atovaquone resistance in Plasmodium falciparum during second-line atovaquone-proguanil treatment in South America.
Legrand E; Demar M; Volney B; Ekala MT; Quinternet M; Bouchier C; Fandeur T; Rogier C; Carme B; Puijalon OM; Esterre P
Antimicrob Agents Chemother; 2007 Jun; 51(6):2280-1. PubMed ID: 17438062
[No Abstract] [Full Text] [Related]
2. First case of emergence of atovaquone-proguanil resistance in Plasmodium falciparum during treatment in a traveler in Comoros.
Savini H; Bogreau H; Bertaux L; Bouchiba H; Kraemer P; Parzy D; Garnotel E; Rogier C; Simon F; Pradines B
Antimicrob Agents Chemother; 2008 Jun; 52(6):2283-4. PubMed ID: 18411319
[No Abstract] [Full Text] [Related]
3. Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations.
Musset L; Bouchaud O; Matheron S; Massias L; Le Bras J
Microbes Infect; 2006 Sep; 8(11):2599-604. PubMed ID: 16962361
[TBL] [Abstract][Full Text] [Related]
4. Atovaquone and proguanil hydrochloride for treatment of malaria.
Kremsner PG; Looareesuwan S; Chulay JD
J Travel Med; 1999 May; 6 Suppl 1():S18-20. PubMed ID: 23573548
[TBL] [Abstract][Full Text] [Related]
5. In vitro atovaquone/proguanil susceptibility and characterization of the cytochrome b gene of Plasmodium falciparum from different endemic regions of Thailand.
Khositnithikul R; Tan-Ariya P; Mungthin M
Malar J; 2008 Jan; 7():23. PubMed ID: 18226262
[TBL] [Abstract][Full Text] [Related]
6. Atovaquone and proguanil hydrochloride for prophylaxis of malaria.
Shanks GD; Kremsner PG; Sukwa TY; van der Berg JD; Shapiro TA; Scott TR; Chulay JD;
J Travel Med; 1999 May; 6 Suppl 1():S21-7. PubMed ID: 23573549
[TBL] [Abstract][Full Text] [Related]
7. Atovaquone-proguanil resistance in imported falciparum malaria in a young child.
Rose GW; Suh KN; Kain KC; Le Saux N; McCarthy AE
Pediatr Infect Dis J; 2008 Jun; 27(6):567-9. PubMed ID: 18434932
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of artesunate-amodiaquine, atovaquone-proguanil, and artesunate-atovaquone-proguanil for the treatment of uncomplicated falciparum malaria in children.
Tahar R; Almelli T; Debue C; Foumane Ngane V; Djaman Allico J; Whegang Youdom S; Basco LK
J Infect Dis; 2014 Dec; 210(12):1962-71. PubMed ID: 24943722
[TBL] [Abstract][Full Text] [Related]
9. Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers.
Musset L; Pradines B; Parzy D; Durand R; Bigot P; Le Bras J
J Antimicrob Chemother; 2006 Jan; 57(1):110-5. PubMed ID: 16319183
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of atovaquone-proguanil in treating imported malaria in Japan: the second report from the research group.
Kimura M; Koga M; Kikuchi T; Miura T; Maruyama H
Parasitol Int; 2012 Sep; 61(3):466-9. PubMed ID: 22484597
[TBL] [Abstract][Full Text] [Related]
11. [Atovaquone-proguanil treatment failure in Plasmodium falciparum].
Contentin L; Grammatico-Guillon L; Desoubeaux G; Baron S; Thanh HD
Presse Med; 2011 Nov; 40(11):1081-3. PubMed ID: 21570798
[No Abstract] [Full Text] [Related]
12. Atovaquone-proguanil: report from the CDC expert meeting on malaria chemoprophylaxis (II).
Boggild AK; Parise ME; Lewis LS; Kain KC
Am J Trop Med Hyg; 2007 Feb; 76(2):208-23. PubMed ID: 17297027
[TBL] [Abstract][Full Text] [Related]
13. Detection of atovaquone-proguanil resistance conferring mutations in Plasmodium falciparum cytochrome b gene in Luanda, Angola.
Pimentel S; Nogueira F; Benchimol C; Quinhentos V; Bom J; Varandas L; do Rosário V; Bernardino L
Malar J; 2006 Apr; 5():30. PubMed ID: 16597338
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of atovaquone-proguanil for treatment of acute multidrug-resistant Plasmodium falciparum malaria in Thailand.
Krudsood S; Patel SN; Tangpukdee N; Thanachartwet W; Leowattana W; Pornpininworakij K; Boggild AK; Looareesuwan S; Kain KC
Am J Trop Med Hyg; 2007 Apr; 76(4):655-8. PubMed ID: 17426165
[TBL] [Abstract][Full Text] [Related]
15. Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.
Lacy MD; Maguire JD; Barcus MJ; Ling J; Bangs MJ; Gramzinski R; Basri H; Sismadi P; Miller GB; Chulay JD; Fryauff DJ; Hoffman SL; Baird JK
Clin Infect Dis; 2002 Nov; 35(9):e92-5. PubMed ID: 12384852
[TBL] [Abstract][Full Text] [Related]
16. Atovaquone-Proguanil Remains a Potential Stopgap Therapy for Multidrug-Resistant Plasmodium falciparum in Areas along the Thai-Cambodian Border.
Saunders DL; Chaorattanakawee S; Gosi P; Lanteri C; Somethy S; Kuntawunginn W; Ittiverakul M; Chann S; Gregory C; Chuor CM; Prom S; Spring MD; Lon C
Antimicrob Agents Chemother; 2015 Dec; 60(3):1896-8. PubMed ID: 26711753
[TBL] [Abstract][Full Text] [Related]
17. Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports.
Färnert A; Lindberg J; Gil P; Swedberg G; Berqvist Y; Thapar MM; Lindegårdh N; Berezcky S; Björkman A
BMJ; 2003 Mar; 326(7390):628-9. PubMed ID: 12649236
[No Abstract] [Full Text] [Related]
18. Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune north American traveller to west Africa.
Kuhn S; Gill MJ; Kain KC
Am J Trop Med Hyg; 2005 Apr; 72(4):407-9. PubMed ID: 15827276
[TBL] [Abstract][Full Text] [Related]
19. Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa.
Schwartz E; Bujanover S; Kain KC
Clin Infect Dis; 2003 Aug; 37(3):450-1. PubMed ID: 12884171
[TBL] [Abstract][Full Text] [Related]
20. Malarone treatment failure not associated with previously described mutations in the cytochrome b gene.
Wichmann O; Muehlen M; Gruss H; Mockenhaupt FP; Suttorp N; Jelinek T
Malar J; 2004 Jun; 3():14. PubMed ID: 15186499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
